Letters to the editors [1]

Tropical Medicine and International Health

Volumn 11, Issue 12, 2006, Pages 1898-1899

  Ashley, Elizabeth ^a,b   McGready, Rose ^a,b   Singhasivanon, Pratap ^a   Nosten, François ^a,b   Carrara, Verena ^b   Price, Ric ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE PLUS MEFLOQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; MEFLOQUINE; UNCLASSIFIED DRUG; ARTEMISININ DERIVATIVE; ARTESUNATE; SESQUITERPENE;

CAMBODIA; DRUG EFFICACY; DRUG MONITORING; DRUG TREATMENT FAILURE; HUMAN; LETTER; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; RECURRENT INFECTION; THAILAND; TREATMENT OUTCOME; VIET NAM; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; NOTE;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; MEFLOQUINE; SESQUITERPENES; TREATMENT OUTCOME;

EID: 33751354263     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01749_1.x     Document Type: Letter

References (9)

1. Ashley EA, McGready R, Hutagalung R et al. (2005) A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin- piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clinical Infectious Diseases 41, 425-432 (Epub 15 July 2005).
2. Myint HY, Tipmanee P, Nosten F et al. (2004) A systematic overview of published antimalarial drug trials. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 73-81 (Review).
3. Nosten F, ter Kuile F, Chongsuphajaisiddhi T et al. (1991) Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337, 1140-1143.
4. Nosten F, Luxemburger C, ter Kuile F et al. (1994) Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. Journal of Infectious Diseases 170, 971-977.
5. Nosten F, McGready R, Ashley E & White NJ (2005) Malaria misconceptions. Lancet 365, 653.
6. Simpson JA, Watkins ER, Price RN et al. (2000) Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.. Antimicrobial Agents and Chemotherapy 44, 3414-3424.
7. Tangpukdee N, Krudsood S, Thanachartwet W et al. (2005) An open randomized clinical trial of Artekin vs. artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 36, 1085-1091.
8. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A & Wongsrichanalai C (2006) In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Tropical Medicine and International Health 11, 211-219.
9. WHO (2006) WHO Guidelines for the Treatment of Malaria. (WHO/HTM/MAL 2006.1108) World Health Organization, Geneva, Switzerland.